MEDICINES CO /DE·4

Jan 23, 5:01 PM ET

MEDICINES CO /DE 4

4 · MEDICINES CO /DE · Filed Jan 23, 2014

Insider Transaction Report

Form 4
Period: 2014-01-21
Antinori Paul Michael
SVP and General Counsel
Transactions
  • Exercise/Conversion

    Common Stock

    2014-01-21$7.31/sh+10,500$76,75541,912 total
  • Sale

    Common Stock

    2014-01-21$38.09/sh20,000$761,81431,412 total
  • Sale

    Common Stock

    2014-01-21$37.82/sh7,000$264,72031,412 total
  • Exercise/Conversion

    Stock Option (right-to-buy)

    2014-01-2110,5002,000 total
    Exercise: $7.31Exp: 2020-02-19Common Stock (10,500 underlying)
  • Sale

    Common Stock

    2014-01-21$38.00/sh10,500$399,02531,412 total
  • Exercise/Conversion

    Common Stock

    2014-01-21$14.82/sh+20,000$296,40051,412 total
  • Exercise/Conversion

    Common Stock

    2014-01-21$17.45/sh+7,000$122,15038,412 total
  • Sale

    Common Stock

    2014-01-21$38.05/sh383$14,57431,029 total
  • Exercise/Conversion

    Stock Option (right-to-buy)

    2014-01-217,0006,333 total
    Exercise: $17.45Exp: 2021-02-18Common Stock (7,000 underlying)
  • Exercise/Conversion

    Stock Option (right-to-buy)

    2014-01-2120,0008,330 total
    Exercise: $14.82Exp: 2020-09-17Common Stock (20,000 underlying)
Footnotes (9)
  • [F1]The common stock sales were effected pursuant to a Rule 10b5-1 program adopted by the reporting person on December 13, 2013.
  • [F2]Represents the weighted average sales price of the shares sold ranging from a low of $37.77 to a high of $38.31 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
  • [F3]Represents the weighted average sales price of the shares sold ranging from a low of $37.72 to a high of $38.46 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
  • [F4]Represents the weighted average sales price of the shares sold ranging from a low of $37.70 to a high of $38.06 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
  • [F5]Represents the weighted average sales price of the shares sold ranging from a low of $38.05 to a high of $38.06 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
  • [F6]This option vests in forty-eight equal monthly installments beginning on March 19, 2010.
  • [F7]This option vests in forty-eight equal monthly installments beginning October 17, 2010.
  • [F8]This option vests in forty-eight equal monthly installments beginning on March 18, 2011.
  • [F9]Not applicable.

Documents

1 file
  • 4
    edgar.xmlPrimary

    FORM 4 -